IRIS Accounts Production v24.1.0.578 06254586 director 1.1.23 31.12.23 31.12.23 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh062545862022-12-31062545862023-12-31062545862023-01-012023-12-31062545862021-12-31062545862022-01-012022-12-31062545862022-12-3106254586ns15:EnglandWales2023-01-012023-12-3106254586ns14:PoundSterling2023-01-012023-12-3106254586ns10:Director12023-01-012023-12-3106254586ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3106254586ns10:SmallEntities2023-01-012023-12-3106254586ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3106254586ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3106254586ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3106254586ns10:FullAccounts2023-01-012023-12-310625458612023-01-012023-12-3106254586ns10:OrdinaryShareClass12023-01-012023-12-3106254586ns10:RegisteredOffice2023-01-012023-12-3106254586ns5:CurrentFinancialInstruments2023-12-3106254586ns5:CurrentFinancialInstruments2022-12-3106254586ns5:Non-currentFinancialInstruments2023-12-3106254586ns5:Non-currentFinancialInstruments2022-12-3106254586ns5:ShareCapital2023-12-3106254586ns5:ShareCapital2022-12-3106254586ns5:RetainedEarningsAccumulatedLosses2023-12-3106254586ns5:RetainedEarningsAccumulatedLosses2022-12-3106254586ns5:NetGoodwill2023-01-012023-12-3106254586ns5:FurnitureFittings2023-01-012023-12-3106254586ns5:ComputerEquipment2023-01-012023-12-3106254586ns5:NetGoodwill2022-12-3106254586ns5:NetGoodwill2023-12-3106254586ns5:NetGoodwill2022-12-3106254586ns5:FurnitureFittings2022-12-3106254586ns5:ComputerEquipment2022-12-3106254586ns5:FurnitureFittings2023-12-3106254586ns5:ComputerEquipment2023-12-3106254586ns5:FurnitureFittings2022-12-3106254586ns5:ComputerEquipment2022-12-3106254586ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3106254586ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3106254586ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2023-12-3106254586ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2022-12-3106254586ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-12-3106254586ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2022-12-3106254586ns5:DeferredTaxation2022-12-3106254586ns5:DeferredTaxation2023-01-012023-12-3106254586ns5:DeferredTaxation2023-12-3106254586ns10:OrdinaryShareClass12023-12-31
REGISTERED NUMBER: 06254586 (England and Wales)












UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2023

FOR

TICEHURST PHARMACY LIMITED

TICEHURST PHARMACY LIMITED (REGISTERED NUMBER: 06254586)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023










Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


TICEHURST PHARMACY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2023







DIRECTOR: Mr H G Desai





REGISTERED OFFICE: The Pharmacy
Church Street
Ticehurst
Wadhurst
East Sussex
TN5 7AA





REGISTERED NUMBER: 06254586 (England and Wales)





ACCOUNTANTS: Acuity Professional Partnership LLP
Unit 2.02 High Weald House
Glovers End
Bexhill
East Sussex
TN39 5ES

TICEHURST PHARMACY LIMITED (REGISTERED NUMBER: 06254586)

STATEMENT OF FINANCIAL POSITION
31 DECEMBER 2023

31.12.23 31.12.22
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 97,500 112,500
Tangible assets 5 5,489 5,450
102,989 117,950

CURRENT ASSETS
Stocks 6 45,120 39,975
Debtors 7 893,419 399,109
Cash at bank 290,390 601,781
1,228,929 1,040,865
CREDITORS
Amounts falling due within one year 8 589,106 324,321
NET CURRENT ASSETS 639,823 716,544
TOTAL ASSETS LESS CURRENT
LIABILITIES

742,812

834,494

CREDITORS
Amounts falling due after more than one year 9 (14,167 ) (24,167 )

PROVISIONS FOR LIABILITIES 11 (1,043 ) (1,036 )
NET ASSETS 727,602 809,291

CAPITAL AND RESERVES
Called up share capital 12 200 200
Retained earnings 727,402 809,091
SHAREHOLDERS' FUNDS 727,602 809,291

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

TICEHURST PHARMACY LIMITED (REGISTERED NUMBER: 06254586)

STATEMENT OF FINANCIAL POSITION - continued
31 DECEMBER 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 19 September 2024 and were signed by:





Mr H G Desai - Director


TICEHURST PHARMACY LIMITED (REGISTERED NUMBER: 06254586)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023


1. STATUTORY INFORMATION

Ticehurst Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

TURNOVER
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

GOODWILL
Goodwill, being the amount paid in connection with the acquisition of business in 2007 is being amortised evenly over its useful life of 20 years.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 10% on cost
Computer equipment - 33% on cost

STOCKS
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

TICEHURST PHARMACY LIMITED (REGISTERED NUMBER: 06254586)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023


2. ACCOUNTING POLICIES - continued

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 7 (2022 - 6 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
Cost
At 1 January 2023
and 31 December 2023 300,000
Amortisation
At 1 January 2023 187,500
Amortisation for year 15,000
At 31 December 2023 202,500
Net book value
At 31 December 2023 97,500
At 31 December 2022 112,500

5. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
Cost
At 1 January 2023 50,331 4,336 54,667
Additions - 2,610 2,610
At 31 December 2023 50,331 6,946 57,277
Depreciation
At 1 January 2023 47,256 1,961 49,217
Charge for year 349 2,222 2,571
At 31 December 2023 47,605 4,183 51,788
Net book value
At 31 December 2023 2,726 2,763 5,489
At 31 December 2022 3,075 2,375 5,450

TICEHURST PHARMACY LIMITED (REGISTERED NUMBER: 06254586)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023


6. STOCKS
31.12.23 31.12.22
£    £   
Stocks 45,120 39,975

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Trade debtors - 48,551
Amounts owed by group undertakings 750,275 316,395
Other debtors 143,144 34,163
893,419 399,109

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Bank loans and overdrafts (see note 10) 10,000 20,000
Trade creditors 119,258 140,618
Amounts owed to group undertakings 220,735 10,000
Taxation and social security 225,754 140,702
Other creditors 13,359 13,001
589,106 324,321

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.12.23 31.12.22
£    £   
Bank loans (see note 10) 14,167 24,167

10. LOANS

An analysis of the maturity of loans is given below:

31.12.23 31.12.22
£    £   
Amounts falling due within one year or on demand:
Bank loans 10,000 20,000

Amounts falling due between one and two years:
Bank loans - 1-2 years 10,000 10,000

Amounts falling due between two and five years:
Bank loans - 2-5 years 4,167 14,167

TICEHURST PHARMACY LIMITED (REGISTERED NUMBER: 06254586)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023


11. PROVISIONS FOR LIABILITIES
31.12.23 31.12.22
£    £   
Deferred tax 1,043 1,036

Deferred
tax
£   
Balance at 1 January 2023 1,036
Provided during year 7
Balance at 31 December 2023 1,043

12. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.12.23 31.12.22
value: £    £   
200 Ordinary £1 200 200